Internal Medicine, Cardiovascular Disease · Los Angeles, CA
NPI
1043244296
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6333 Wilshire Blvd, #200
Los Angeles, CA, 90048
Phone (323) 653-2504
Groups this clinician bills Medicare through
Medicare paid, 2024
$524K
7,544 services
Medicare patients, 2024
1,164
Average age 79
Drug cost, 2024
$10.4M
47,917 prescriptions
Company payments, 2025
$4,108
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary Reznik was code 93000 (electrocardiogram), 2,111 times for 1,063 patients. In total Gary Reznik billed 7,544 services in 47 codes, and Medicare paid $524K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 2,111 | 1,063 | $11.34 | $24K |
| 99214 Office E&M - Established | Office | 1,496 | 836 | $106.83 | $160K |
| 36415 Venipuncture Blood Collection | Office | 753 | 488 | $8.65 | $6,513 |
| 93306 Echocardiography (TTE/TEE) | Office | 496 | 492 | $171.75 | $85K |
| 99213 Office E&M - Established | Office | 358 | 273 | $74.85 | $27K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 342 | 342 | $167.53 | $57K |
| 99232 Hospital E&M - Subsequent | Facility | 294 | 76 | $64.78 | $19K |
| 99231 Hospital E&M - Subsequent | Facility | 241 | 75 | $40.52 | $9,764 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 167 | 167 | $139.87 | $23K |
| 99205 Office E&M - New | Office | 155 | 155 | $173.52 | $27K |
| 99222 Hospital E&M - Initial | Facility | 130 | 93 | $106.96 | $14K |
| 99215 Office E&M - Established | Office | 128 | 115 | $153.98 | $20K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 110 | 110 | $26.76 | $2,944 |
| 93280 External Electrocardiographic Monitoring | Office | 110 | 68 | $63.45 | $6,980 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 105 | 74 | $44.91 | $4,716 |
By year: 2022 $431K for 6,636 services; 2023 $459K for 6,864 services; 2024 $524K for 7,544 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 753 | 488 | $8.65 | $6,513 |
Medicare prescription drug claims, 2024
In 2024, the drug Gary Reznik prescribed most often to Medicare patients was Rosuvastatin Calcium, with 3,161 prescriptions and refills. In total Gary Reznik wrote 47,917 Medicare prescriptions that cost $10.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 3,161 | 4,247 | 435 | $19K |
| Nebivolol Hcl Generic | 3,102 | 3,477 | 348 | $154K |
| Edarbi Azilsartan Medoxomil | 2,142 | 2,288 | 239 | $558K |
| Hydralazine Hcl Generic | 1,978 | 2,081 | 226 | $11K |
| Icosapent Ethyl Generic | 1,850 | 1,899 | 252 | $306K |
| Mounjaro Tirzepatide | 1,751 | 1,782 | 214 | $1.8M |
| Pitavastatin Calcium Generic | 1,564 | 1,722 | 205 | $327K |
| Metoprolol Succinate Generic | 1,554 | 1,810 | 186 | $12K |
| Xarelto Rivaroxaban | 1,509 | 1,607 | 160 | $920K |
| Vascepa Icosapent Ethyl | 1,469 | 1,546 | 201 | $533K |
| Edarbyclor Azilsartan Med/Chlorthalidone | 1,144 | 1,212 | 131 | $285K |
| Amiodarone Hcl Generic | 1,126 | 1,222 | 126 | $17K |
| Olmesartan Medoxomil Generic | 1,048 | 1,366 | 169 | $8,131 |
| Repatha Sureclick Evolocumab | 999 | 1,027 | 112 | $560K |
| Levothyroxine Sodium Generic | 964 | 1,112 | 112 | $3,781 |
Brand drugs: 16,917 claims; generic drugs: 30,945 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary Reznik $4,108 ($4,108 in general payments such as food, travel and fees) from 33 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $410.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $410 |
| Medtronic, Inc. MDT | 3 | $377 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $340 |
| Radius Health, Inc. | 11 | $293 |
| Amgen Inc. AMGN | 14 | $286 |
| Abbvie Inc. ABBV | 11 | $245 |
| UCB, Inc. UCB.BR | 6 | $205 |
| Edwards Lifesciences Corporation EW | 4 | $183 |
| Novo Nordisk Inc NVO | 7 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $168 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.